News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
647,605 Results
Type
Article (54381)
Company Profile (558)
Press Release (592666)
Section
Business (183413)
Career Advice (2534)
Deals (33384)
Drug Delivery (77)
Drug Development (74508)
Employer Resources (130)
FDA (15446)
Job Trends (15618)
News (314751)
Policy (30825)
Tag
Academia (2769)
Africa (836)
Alliances (44384)
Alzheimer's disease (1172)
Approvals (15376)
Arizona (115)
Artificial intelligence (71)
Asia (38126)
Australia (6832)
Bankruptcy (274)
Best Places to Work (11979)
Biotechnology (398)
C2C Services and Suppliers (66477)
California (1991)
Canada (935)
Cancer (488)
Career advice (2091)
Cell therapy (126)
China (148)
Clinical research (58071)
Collaboration (140)
Colorado (85)
Compensation (80)
Connecticut (85)
COVID-19 (2338)
Cystic fibrosis (76)
Data (318)
Diabetes (78)
Diagnostics (6249)
Drug pricing (65)
Earnings (69598)
Employer resources (111)
Europe (87128)
Events (105984)
Executive appointments (166)
FDA (15680)
Florida (276)
Funding (151)
Gene therapy (89)
Georgia (69)
GLP-1 (485)
Government (4171)
Healthcare (20059)
Hotbed/Location (434177)
Illinois (270)
Indiana (157)
Infectious disease (2363)
Inflammatory bowel disease (98)
Interviews (430)
IPO (16404)
Job creations (3838)
Job search strategy (1836)
Kansas (93)
Layoffs (382)
Legal (6797)
Lung cancer (107)
Manufacturing (86)
Maryland (432)
Massachusetts (1706)
Medical device (13755)
Medtech (13759)
Mergers & acquisitions (16937)
Metabolic disorders (222)
Michigan (137)
Minnesota (235)
Neuroscience (1324)
New Jersey (609)
New York (619)
NextGen Class of 2024 (7252)
Non-profit (4922)
North Carolina (693)
Northern California (844)
Obesity (121)
Ohio (110)
Opinion (210)
Patents (73)
Pennsylvania (597)
People (53510)
Pharmaceutical (103)
Phase I (17871)
Phase II (25216)
Phase III (19747)
Pipeline (110)
Postmarket research (2488)
Preclinical (7761)
Press Release (68)
Radiopharmaceuticals (248)
Rare diseases (131)
Real estate (6285)
Regulatory (20807)
Research institute (2508)
Resumes & cover letters (410)
South America (1153)
Southern California (782)
Startups (3426)
Texas (257)
United States (9147)
Vaccines (425)
Washington State (282)
Weight loss (108)
Date
Today (20)
Last 7 days (627)
Last 30 days (2477)
Last 365 days (38359)
2024 (27270)
2023 (41378)
2022 (50566)
2021 (55679)
2020 (55836)
2019 (49794)
2018 (37165)
2017 (31597)
2016 (30271)
2015 (35626)
2014 (28414)
2013 (28117)
2012 (24418)
2011 (24736)
2010 (23263)
647,605 Results for "sanofi aventis new jersey".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
2024 Sanofi Biogenius Canada Grants open for applications
sanofi-aventis Canada inc. is pleased to announce that applications for the 2024 Sanofi Biogenius Canada Grants are now open.
March 19, 2024
·
4 min read
Sanofi Opens New Advanced Vaccines Facility, Strengthening Its Commitment to Biomanufacturing in Canada
Sanofi, a global healthcare company, announced the opening of a new state-of-the-art pediatric and adult vaccine manufacturing facility at its Toronto Campus.
May 30, 2024
·
6 min read
ProBio Expands Plasmid DNA and Viral Vector Production in New Jersey to Accelerate Delivery of Life-Changing Cell and Gene Therapies
ProBio Inc, a New Jersey-based contract development and manufacturing organization (CDMO), proudly announce the expansion of its plasmid DNA and viral vector manufacturing capabilities with the opening of a new state-of-the-art facility in Hopewell, New Jersey.
June 25, 2024
·
2 min read
Editorial
Roche and Sanofi MS Trials Show Potential, Challenges of Oral BTK Inhibitors
Roche’s fenebrutinib this week scored a mid-stage win in relapsing multiple sclerosis, while Sanofi’s tolebrutinib met the primary endpoint in a Phase III trial for progressive MS but flopped in two late-stage relapsing MS studies.
September 6, 2024
·
3 min read
·
Greg Slabodkin
Business
Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player
While Sanofi restructures and parts with employees from U.S. and Belgian sites, a new company in the GLP-1 space emerges from stealth.
April 23, 2024
·
1 min read
·
Greg Slabodkin, Heather McKenzie, Tyler Patchen
Multiple sclerosis
Roche Touts Phase II MS Data on Heels of Sanofi’s Late-Stage Stumbles
Days after Sanofi reported back-to-back failures for its BTK inhibitor, Roche’s fenebrutinib on Wednesday scored a mid-stage win in relapsing multiple sclerosis, demonstrating near-total elimination of disease activity.
September 4, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
September 4, 2024
·
8 min read
RSV
Sanofi, AstraZeneca Get FDA Approval of New Manufacturing Line to Bolster US Supply of RSV Antibody
The newly approved filling line will be able to provide both 50-mg and 100-mg doses of the respiratory syncytial virus antibody Beyfortus to help meet demand ahead of the 2024/2025 RSV season.
September 17, 2024
·
2 min read
·
Tristan Manalac
Job Trends
5 Top Companies Hiring in New Jersey
Looking for a biopharma job in New Jersey? Check out the BioSpace list of five top companies hiring life sciences professionals like you.
March 27, 2024
·
1 min read
·
Angela Gabriel
GLP-1
As Novo and Lilly Focus on a Few Big Markets, Sanofi Seeks Global Reach for Diabetes GLP-1 Drug
Experts say Novo Nordisk and Eli Lilly’s GLP-1 drugs are unlikely to reach more countries in the near term, but Sanofi’s diabetes treatment has gained ground globally.
August 21, 2024
·
5 min read
·
Patience Asanga
1 of 64,761
Next
